These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24955552)

  • 1. Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients.
    Mokhber N; Abdollahian E; Soltanifar A; Samadi R; Saghebi A; Haghighi MB; Azarpazhooh A
    Pharmacopsychiatry; 2014 Jul; 47(4-5):131-40. PubMed ID: 24955552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
    Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A
    Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.
    Lyketsos CG; DelCampo L; Steinberg M; Miles Q; Steele CD; Munro C; Baker AS; Sheppard JM; Frangakis C; Brandt J; Rabins PV
    Arch Gen Psychiatry; 2003 Jul; 60(7):737-46. PubMed ID: 12860778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.
    Shelton RC; Haman KL; Rapaport MH; Kiev A; Smith WT; Hirschfeld RM; Lydiard RB; Zajecka JM; Dunner DL
    J Clin Psychiatry; 2006 Nov; 67(11):1674-81. PubMed ID: 17196045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
    Hoehn-Saric R; Ninan P; Black DW; Stahl S; Greist JH; Lydiard B; McElroy S; Zajecka J; Chapman D; Clary C; Harrison W
    Arch Gen Psychiatry; 2000 Jan; 57(1):76-82. PubMed ID: 10632236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M
    Arch Gen Psychiatry; 1999 Oct; 56(10):932-9. PubMed ID: 10530636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity profile of venlafaxine and sertraline in major depression: metaregression of double-blind, randomized clinical trials.
    Gibiino S; Marsano A; Serretti A
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):1-8. PubMed ID: 23953038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalization of EEG in depression after antidepressant treatment with sertraline? A preliminary report.
    van der Vinne N; Vollebregt MA; Boutros NN; Fallahpour K; van Putten MJAM; Arns M
    J Affect Disord; 2019 Dec; 259():67-72. PubMed ID: 31437703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
    Schatzberg AF; DeBattista C; Lazzeroni LC; Etkin A; Murphy GM; Williams LM
    Am J Psychiatry; 2015 Aug; 172(8):751-9. PubMed ID: 25815420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial.
    Etkin A; Patenaude B; Song YJ; Usherwood T; Rekshan W; Schatzberg AF; Rush AJ; Williams LM
    Neuropsychopharmacology; 2015 May; 40(6):1332-42. PubMed ID: 25547711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease.
    Munro CA; Longmire CF; Drye LT; Martin BK; Frangakis CE; Meinert CL; Mintzer JE; Porsteinsson AP; Rabins PV; Rosenberg PB; Schneider LS; Weintraub D; Lyketsos CG;
    Am J Geriatr Psychiatry; 2012 Dec; 20(12):1036-44. PubMed ID: 23032478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venlafaxine and sertraline does not affect the expression of genes regulating stress response in female MDD patients.
    Banach E; Szczepankiewicz A; Leszczyńska-Rodziewicz A; Pawlak J; Dmitrzak-Węglarz M; Zaremba D; Twarowska-Hauser J
    Psychiatr Pol; 2017 Dec; 51(6):1029-1038. PubMed ID: 29432501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.
    Weintraub D; Rosenberg PB; Drye LT; Martin BK; Frangakis C; Mintzer JE; Porsteinsson AP; Schneider LS; Rabins PV; Munro CA; Meinert CL; Lyketsos CG;
    Am J Geriatr Psychiatry; 2010 Apr; 18(4):332-40. PubMed ID: 20220589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine.
    Vanderkooy JD; Kennedy SH; Bagby RM
    Can J Psychiatry; 2002 Mar; 47(2):174-80. PubMed ID: 11926080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report.
    van Dinteren R; Arns M; Kenemans L; Jongsma ML; Kessels RP; Fitzgerald P; Fallahpour K; Debattista C; Gordon E; Williams LM
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):1981-90. PubMed ID: 26282359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.
    Barber JP; Barrett MS; Gallop R; Rynn MA; Rickels K
    J Clin Psychiatry; 2012 Jan; 73(1):66-73. PubMed ID: 22152401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caregiver assessment of patients' depression in Alzheimer disease: longitudinal analysis in a drug treatment study.
    Rosenberg PB; Mielke MM; Lyketsos CG
    Am J Geriatr Psychiatry; 2005 Sep; 13(9):822-6. PubMed ID: 16166413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.